Different Levels of Incomplete Terminal Pathway Inhibition by Eculizumab and the Clinical Response of PNH Patients

by Markus J. Harder, Britta Höchsmann, Britta Höchsmann, Arthur Dopler, Markus Anliker, Christof Weinstock, Christof Weinstock, Arne Skerra, Thomas Simmet, Hubert Schrezenmeier, Hubert Schrezenmeier, Christoph Q. Schmidt
Published 2019-07-01